ArticleMethods in molecular biology (Clifton, N.J.)2026
Synthesis of PbS/CdS/ZnS Core/Shell/Shell Quantum Dots for Multiplexed Shortwave Infrared Imaging.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This chapter describes a systematic approach for synthesizing high-quality lead sulfide/cadmium sulfide/zinc sulfide (PbS/CdS/ZnS) core/shell/shell quantum dots (QDs) with tunable emission in the shortwave infrared (SWIR) wavelength range (1000-1700 nm). This protocol details the synthesis of three distinct QD formulations with emission peaks at approximately 1150, 1250, and 1515 nm, enabling multiplexed in vivo imaging applications. The synthetic route involves three key steps: (1) size-controlled synthesis of PbS cores through hot injection precipitation, (2) formation of a CdS shell through cation exchange, and (3) deposition of a ZnS outer shell using a low-temperature single-source precursor approach to enhance stability while preserving optical properties. The protocol ends with a postsynthetic surface treatment to enhance quantum yield. These QDs exhibit excellent brightness, narrow emission linewidths, and superior stability compared to conventional SWIR emitters, making them ideal for deep-tissue, multiplexed imaging applications.
Indexed as
Identifiers
42563047What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.